Weaver IC, Diorio J, Seckl JR, Szyf M, Meaney MJ (2004)
ParabPChaudharyPMukhtarSMoradiAKodaliAOkoyeCet alRole of glucagon-like peptide-1 (GLP-1) receptor agonists in cardiovascular risk management in patients with type 2 diabetes mellitus: a systematic review
Med Sci Sport Exer
Design An animal wound-healing model comparing the full protein and the short fragment
These medicines are licensed for different indications some specifically for type 2 diabetes (e.g., Ozempic, Trulicity), while others are licensed for weight management (e.g., Wegovy, Saxenda) in line with NICE guidance
Sin embargo, los resultados no han sido tan sorprendentes como esperaba, aunque s veo algunas mejoras en mi piel